Such a plan is essential to ensure operations continue during a digital disruption, says Tony Black, global director of healthcare, privacy and digital transformation at Kyndryl.
Artificial intelligence has demonstrated value as an assistant for physicians, helping care teams via disease-identifying algorithms and large language models that record notes during patient visits. But a new study from Stanford Medicine shows the potential of AI as a facilitator – one that helps doctors and nurses connect to achieve more efficient patient care.
Founder and president of Medonations Marina El Khawand realized her calling after a 2020 explosion in Beirut, when she helped a woman affected by a blast who badly needed her asthma medication.
Guardrails can’t be fully implemented until AI is defined, says Patricia MacTaggart, program director and teaching instructor at George Washington University, who is a 2024 Changemaker Award recipient.
The first quarter of 2024 saw a significant uptick in merger and acquisition activity, with 20 announced transactions – which, according to Kaufman Hall, represents the strongest first quarter since Q1 2020, just before the start of the COVID-19 pandemic.
The House Subcommittee on Health and witnesses slammed insurers Tuesday for continuing to make money during the Change cyberattack crisis while hospitals and health systems suffer revenue losses and some physician practices are on the brink of bankruptcy.
Suki recently joined forces with Amwell’s Converge telehealth platform, says Punit Soni, CEO & founder of Suki AI.
Elevance Health and private investment firm Clayton, Dublier and Rice (CD&R) have agreed to form a strategic partnership meant to accelerate innovation in primary care delivery, with an eye toward improving experience and outcomes. The effort will bring together certain care delivery and enablement assets of Elevance Health’s Carelon Health and CD&R portfolio companies apree […]
This includes large print, braille, audio recordings and the newest piece, providing documents in the dominant language, says Ernie Crawford, president and CEO of Crawford Technologies.
The Department of Justice has filed a False Claims Act complaint against Regeneron Pharmaceuticals, a New York-based pharmaceutical company, over allegedly inflating Medicare reimbursement rates for Eylea, an injection therapy approved for retinal diseases. It was approved by the Food and Drug Administration to treat, among other conditions, neovascular age-related macular degeneration. WHAT’S THE IMPACT